PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 266 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $9,717 | +831.6% | 288 | +747.1% | 0.00% | – |
| Q3 2023 | $1,043 | -78.7% | 34 | -72.1% | 0.00% | – |
| Q2 2023 | $4,889 | +13.0% | 122 | +15.1% | 0.00% | – |
| Q1 2023 | $4,326 | +108050.0% | 106 | +2.9% | 0.00% | – |
| Q4 2022 | $4 | -99.8% | 103 | +178.4% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 37 | +8.8% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 34 | -15.0% | 0.00% | – |
| Q1 2022 | $3,000 | +200.0% | 40 | +263.6% | 0.00% | – |
| Q4 2021 | $1,000 | -100.0% | 11 | -99.8% | 0.00% | -100.0% |
| Q3 2017 | $215,387,000 | -17.6% | 5,736 | +4.7% | 0.02% | -21.7% |
| Q2 2017 | $261,301,000 | +2.0% | 5,478 | -2.5% | 0.02% | -4.2% |
| Q1 2017 | $256,226,000 | – | 5,619 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |